Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-02 17:40:14 - browse：834

Illustration of sound waves coming out of an ear and at the end of these waves we have a figure trying to push back against them and contain them. -- health coverage from STAT — Advances in gene therapy could eventually "cure" many forms of congenital deafness. The changes have many deaf people worried about the future of their communities. Eros Devishi for STAT

When Yilai Shu was training to be an otolaryngologist in Shanghai, in the mid 2000s, he often met parents with congenitally deaf kids.

“They always asked me, ‘Do you have any drugs to treat our kids?’ said Shu, who is hearing and a professor at Fudan University in China. “That’s what really inspired me to think about developing a drug.”

Decades later, Shu is closer than ever to such a drug. In October, he presented extraordinary data at a conference: His team had successfully enabled hearing in four congenitally deaf children using gene therapy. The work is the culmination of decades of genetic research and has spurred companies like Regeneron and Eli Lilly to swoop in and back other groups developing similar treatments.

The hearing gains are modest and the technology is currently limited to a type of deafness that only affects 1% to 8% of deaf people globally, but some experts suggest that gene therapy could eventually apply to as many as half of all congenitally deaf people. These treatments would have massive implications for the 12,000 kids born with hearing loss in the United States every year.

“This has been the dream of our field for 30-plus years to come up with a molecular treatment to give people real, natural hearing, that they were originally intended to have,” said Larry Lustig, a hearing otolaryngologist at Columbia University who is leading a Regeneron-backed trial showing promising results using gene therapy to treat deafness. “This is going to be transformative.”

But this transformative technology faces a problem: not all deaf people want it.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

focus

WSS

The most pressing bird flu mysteries scientists want answered

Senators tussle over abortion against the backdrop of a presidential campaign

The most pressing bird flu mysteries scientists want answered

RSV injection headlines need to be accurate for good uptake

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

STAT wants to know your pick for a great summer read or listen

leisure time

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Hollywood unions extend contract negotiations for actors

Stopping antidepressants leads to symptoms for 1 in 6 patients

Alkermes shareholders re

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Medical records are filled with copy

The United States is paying nearly triple for new Covid vaccines

Supreme Court strikes down use of affirmative action

How CO2 helps viruses stay alive longer in the air

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study points to new risk in gene therapy death of Terry Horgan

explore

Elevance PBM president out as customers face prescription chaos

CRISPR base editing slashes cholesterol levels in monkeys

Flu, Covid vaccination rates decline, new survey data show

Medicare innovation center doesn’t save money, experts say

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Finland to offer bird flu vaccine to select groups of people, a possible global first

hotspot

focus

leisure time

hotspot